Diabetes mellitus Posts on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Which insulin is better for reducing blood glucose levels before hypoglycemia occurs?

Posted by on Mar 28, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared two insulin types – degludec (Tresiba) and glargine (Lantus) – to see which was better at reducing blood glucose levels before hypoglycemia (dangerously low blood glucose levels) occurred. The study found that degludec improved blood glucose levels for longer than glargine before patients experienced...

Read More

Can metformin help improve mental function in patients with type 2 diabetes?

Posted by on Mar 25, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study looked at whether metformin (Glucophage) therapy improved mental functioning in patients with type 2 diabetes. The authors concluded that metformin significantly improved mental functioning in these patients. Some background Metformin is recommended as a first-line treatment for patients with type 2 diabetes (T2D). Most...

Read More

Can the Mediterranean diet improve the quality of life of patients with Type 1 diabetes?

Posted by on Mar 7, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined if patients with Type 1 diabetes (T1D) who followed a healthy or Mediterranean diet had a higher quality of life. The authors found that patients who followed the Mediterranean diet had a better quality of life, but neither diet improved patients’ satisfaction with treatment. Some background An essential...

Read More

Can traditional Chinese medicine help treat vision loss in patients with diabetes?

Posted by on Mar 3, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study looked at whether traditional Chinese medicine (TCM) can help treat vision loss in patients with diabetes. This study found that TCM may help improve eye function and blood glucose levels for patients with diabetes who have DR. Some background In diabetes mellitus, patients have high levels of glucose (sugar) in...

Read More

Can SGLT2 inhibitors help slow down kidney disease in patients with type 2 diabetes?

Posted by on Jan 30, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study investigated whether sodium-glucose cotransporter 2 (SGLT2) inhibitors could help slow down the progression of kidney disease in patients with type 2 diabetes (T2D). This study concluded that SGLT2 inhibitors slowed down kidney function decline compared to other anti-diabetes medications. Some background T2D often leads to...

Read More

Evaluating a combination therapy for the treatment of type 2 diabetes

Posted by on Jan 30, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of a combination treatment between sodium-glucose cotransporter 2 (SGLT) inhibitors and glucagon-like peptide 1 (GLP1) receptor agonists for patients with Type 2 diabetes (T2D). This study concluded that combination treatment improved blood glucose control and reduced weight loss for...

Read More

Long term differences in blood glucose control between adults using multiple daily injections vs insulin pumps

Posted by on Jan 26, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study wanted to find out if people with type 1 diabetes who use insulin pumps have fewer changes in their blood glucose control than those who use multiple daily injections. The study found that the patients who used insulin pumps had fewer changes in blood glucose control than those on multiple daily...

Read More

Does dapagliflozin protect kidney function in patients with diabetes?

Posted by on Dec 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the effect of dapagliflozin (Farxiga) on kidney disease in patients with type 2 diabetes. It found patients treated with dapagliflozin were significantly less likely to have a decline in kidney function. Some background In type 2 diabetes (T2D), the body no longer regulates blood sugar well. If blood sugar is not...

Read More

Can thiazolidinediones help lower Parkinson’s disease risk in patients with diabetes?

Posted by on Dec 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study investigated whether thiazolidinediones (TZDs) can help lower the risk of Parkinson’s disease (PD) in patients with type 2 diabetes (T2D). The authors concluded that TZDs were associated with a lower risk of PD in these patients. Some background Although anti-diabetes medications can help lower blood sugar...

Read More

Evaluating risk of low blood sugar in patients with diabetes taking insulin degludec

Posted by on Dec 25, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of switching to insulin degludec (Tresiba) in patients with diabetes mellitus. This study concluded that patients had better blood glucose control and a lower risk of low blood sugar after switching. Some background Insulin therapy is the typical first-line treatment for patients...

Read More